Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 1
2021 3
2022 2
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Patients avec cancers thoraciques et COVID-19 : au cœur de la tempête: Patients with chest cancer and COVID-19: at the heart of the storm.
Gounant V, Brosseau S, Soussi G, Pluvy J, Guezzour N, Vauchier C, Brouk Z, Namour C, Zalcman G. Gounant V, et al. Among authors: namour c. Rev Malad Respir Actual. 2021 Sep;13(2):2S280-2S291. doi: 10.1016/S1877-1203(21)00121-X. Epub 2021 Oct 11. Rev Malad Respir Actual. 2021. PMID: 34659597 Free PMC article. French.
Grade 3-4 Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer (NSCLC) Patients Are Correlated with Better Outcome: A Real-Life Observational Study.
Guezour N, Soussi G, Brosseau S, Abbar B, Naltet C, Vauchier C, Poté N, Hachon L, Namour C, Khalil A, Trédaniel J, Zalcman G, Gounant V. Guezour N, et al. Among authors: namour c. Cancers (Basel). 2022 Aug 11;14(16):3878. doi: 10.3390/cancers14163878. Cancers (Basel). 2022. PMID: 36010872 Free PMC article.
Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Study Supporting a Third Dose in Patients With Minimal Serologic Response After Two Vaccine Doses.
Gounant V, Ferré VM, Soussi G, Charpentier C, Flament H, Fidouh N, Collin G, Namour C, Assoun S, Bizot A, Brouk Z, Vicaut E, Teixeira L, Descamps D, Zalcman G. Gounant V, et al. Among authors: namour c. J Thorac Oncol. 2022 Feb;17(2):239-251. doi: 10.1016/j.jtho.2021.10.015. Epub 2021 Nov 16. J Thorac Oncol. 2022. PMID: 34798306 Free PMC article.
Definitions, outcomes, and management of hyperprogression in patients with non-small-cell lung cancer treated with immune checkpoint inhibitors.
Abbar B, De Castelbajac V, Gougis P, Assoun S, Pluvy J, Tesmoingt C, Théou-Anton N, Cazes A, Namour C, Khalil A, Gounant V, Besse B, Zalcman G, Brosseau S. Abbar B, et al. Among authors: namour c. Lung Cancer. 2021 Feb;152:109-118. doi: 10.1016/j.lungcan.2020.12.026. Epub 2020 Dec 28. Lung Cancer. 2021. PMID: 33385736